InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Friday, 11/22/2019 7:30:42 AM

Friday, November 22, 2019 7:30:42 AM

Post# of 418
News: $EYEG EyeGate Pharma Hits Primary Endpoint in PRK Pivotal Study

WALTHAM, MA / ACCESSWIRE / November 22, 2019 / EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) ("EyeGate" or "the Company"), a clinical-stage company focused on developing products for treating disorders of the eye, announced today that it has received select topline data, specifically the prima...

Find out more EYEG - EyeGate Pharma Hits Primary Endpoint in PRK Pivotal Study

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.